SEGLUROMET
These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2017
a6aeb99a-ce49-4125-90ce-642df3f1ebad
HUMAN PRESCRIPTION DRUG LABEL
Sep 12, 2023
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ertugliflozin and metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
ertugliflozin and metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
ertugliflozin and metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
ertugliflozin and metformin hydrochloride
Product Details
FDA regulatory identification and product classification information